Vipergen - About the company
Vipergen is an unfunded company based in Copenhagen (Denmark), founded in 2005 by Nils Jakob Vest Hansen. It operates as a Provider of a platform for drug discovery tool and DNA library. Vipergen has not raised any funding yet. The company has 2093 active competitors, including 470 funded and 337 that have exited. Its top competitors include companies like Strand Life Sciences, Synthego and Antheia.
Company Details
Provider of a platform for drug discovery tools and DNA libraries. The two technologies used are YoctoReactor (yR) technology creates vast small molecule libraries in a single tube and Binder Trap Enrichment (BTE) for screening of YR libraries. The system works by synthesis of DNA encoding libraries and then screening those libraries using Binder Trap Enrichment.
- Website
- www.vipergen.com
- Email ID
- *****@vipergen.com
- Phone Number
- +45 **********
Key Metrics
Founded Year
2005
Location
Copenhagen, Denmark
Stage
Unfunded
Ranked
886th among 2093 active competitors
Employee Count
14 as on Jun 30, 2026
Similar Companies
Legal entities associated with Vipergen
Vipergen is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Vipergen Aps CIN: 28851758 , Denmark, Active | - | 18 (As on Mar 31, 2024) |
Sign up to download Vipergen's company profile
Vipergen's funding and investors
Vipergen has not raised any funding rounds yet.
Vipergen's founders and board of directors
Founder? Claim ProfileThe founders of Vipergen is Nils Jakob Vest Hansen.
Here are the details of Vipergen's key team members:
- Nils Jakob Vest Hansen: Founder & CEO of Vipergen.
View details of Vipergen's Founder profiles and Board Members
Vipergen's employee count trend
Vipergen has 14 employees as of Jun 26. Here is Vipergen's employee count trend over the years:
Uncover Vipergen's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vipergen's Competitors and alternates
Top competitors of Vipergen include Strand Life Sciences, Synthego and Antheia. Here is the list of Top 10 competitors of Vipergen, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 73/100 | |
2nd | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
3rd | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
4th | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
5th | _1530865304957.jpg?devicePixelRatio=2&height=30&width=30){kind=logo} Judges Scientific 2002, London (United Kingdom), Public | Acquisition and development of scientific instrument businesses | - | 65/100 | |
6th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
7th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
8th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
9th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
10th | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 63/100 | |
886th | Provider of a platform for drug discovery tool and DNA library | - | - | 28/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Vipergen's competitors? Click here to see the top ones
Vipergen's Investments and acquisitions
Vipergen has made no investments or acquisitions yet.
Reports related to Vipergen
Here is the latest report on Vipergen's sector:
News related to Vipergen
•
Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening Technologies to CustomersContract Pharma•Apr 19, 2024•Aurigene Pharmaceutical, Vipergen
•
•
Casma Therapeutics and Vipergen Enter Into Drug Discovery AgreementBusiness Wire•Dec 01, 2020•Casma Therapeutics, Vipergen
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Vipergen
Explore our recently published companies
- Autocal - Thane based, 2002 founded, Funding Raised company
- Indo Amines - Thane based, 1994 founded, Public company
- Taro International - Haifa based, 1992 founded, Unfunded company
- SmartCart AI - San Francisco based, Unfunded company
- 365 Retail Markets - London based, 2008 founded, Unfunded company
- Bishop Paiute Development Corporation - Bishop based, 2009 founded, Funding Raised company
